COOThe Cooper Companies, Inc.

$14B

Q2 2021 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$720M+37.1% YoY

Gross Profit

$487M67.7% margin

Operating Income

$143M19.9% margin

Net Income

$118M16.3% margin

EPS (Diluted)

$2.36

QoQ Revenue Growth

+5.7%

Cash Flow

Operating Cash Flow

$193M

Free Cash Flow

$143M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$9.0B

Total Liabilities

$2.9B

Stockholders' Equity

$6.2B

Cash & Equivalents

$106M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$720M	$525M	+37.1%
Gross Profit	$487M	$324M	+50.6%
Operating Income	$143M	$29M	+400.7%
Net Income	$118M	$12M	+921.7%

Revenue Segments

Coopervision Segment

$523M73%

Coopersurgical Segment

$197M27%

Geographic Segments

UNITED STATES

$336M47%

Europe

$230M32%

Rest Of World, Excluding United States And Europe

$153M21%

COO Q2 2021 Earnings — The Cooper Companies, Inc. Revenue & Financial Results | Market Cap Arena